<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Mainz Biomed Bv — News on 6ix</title>
<link>https://6ix.com/company/mainz-biomed-bv</link>
<description>Latest news and press releases for Mainz Biomed Bv on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Mon, 20 Apr 2026 04:00:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/mainz-biomed-bv" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6835a02d78dffbe2df108c7c.webp</url>
<title>Mainz Biomed Bv</title>
<link>https://6ix.com/company/mainz-biomed-bv</link>
</image>
<item>
<title>Onto Innovation Announces Strategic Partnership With Leading X-Ray Provider Rigaku To Advance Next-Generation Process Control Solutions</title>
<link>https://6ix.com/company/mainz-biomed-bv/news/onto-innovation-announces-strategic-partnership-with-leading-x-ray-provider-rigaku-to-advance-next-generation-process-control-solutions-47</link>
<guid isPermaLink="true">https://6ix.com/company/mainz-biomed-bv/news/onto-innovation-announces-strategic-partnership-with-leading-x-ray-provider-rigaku-to-advance-next-generation-process-control-solutions-47</guid>
<pubDate>Mon, 20 Apr 2026 04:00:00 GMT</pubDate>
<description>Systems delivered for advanced V-NAND and DRAM metrology, with expanding engagement across top-tier logic and memory customers WILMINGTON, Mass.--(BUSINESS</description>
</item>
<item>
<title>Nanalysis Announces Fourth Quarter and Full Year 2025 Conference Call</title>
<link>https://6ix.com/company/mainz-biomed-bv/news/nanalysis-announces-fourth-quarter-and-full-year-2025-conference-call-1</link>
<guid isPermaLink="true">https://6ix.com/company/mainz-biomed-bv/news/nanalysis-announces-fourth-quarter-and-full-year-2025-conference-call-1</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>Hosting Call at 10am ET on Thursday, April 9thCALGARY, AB, April 2, 2026 /PRNewswire/ - Nanalysis Scientific Corp. ("the Company", TSXV: NSCI, FRA: 1N1), a</description>
</item>
<item>
<title>Premier Air Charter Attends 2026 NBAA Schedulers & Dispatchers Conference to Strengthen Industry Relationships and Explore Emerging Aviation Technologies</title>
<link>https://6ix.com/company/mainz-biomed-bv/news/premier-air-charter-attends-2026-nbaa-schedulers-and-dispatchers-conference-to-strengthen-industry-relationships-and-explore-emerging-aviation-technologies-2</link>
<guid isPermaLink="true">https://6ix.com/company/mainz-biomed-bv/news/premier-air-charter-attends-2026-nbaa-schedulers-and-dispatchers-conference-to-strengthen-industry-relationships-and-explore-emerging-aviation-technologies-2</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>CARLSBAD, Calif., April 02, 2026 (GLOBE NEWSWIRE) -- Premier Air Charter Holdings Inc. (OTCID: PREM) (“Premier Air Charter,” “Premier,” “PAC,” or the</description>
</item>
<item>
<title>Northern Technologies International Corporation to Announce Fiscal 2026 Second-Quarter Financial Results and Host Conference Call</title>
<link>https://6ix.com/company/mainz-biomed-bv/news/northern-technologies-international-corporation-to-announce-fiscal-2026-second-quarter-financial-results-and-host-conference-call-1</link>
<guid isPermaLink="true">https://6ix.com/company/mainz-biomed-bv/news/northern-technologies-international-corporation-to-announce-fiscal-2026-second-quarter-financial-results-and-host-conference-call-1</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>MINNEAPOLIS, April 02, 2026 (GLOBE NEWSWIRE) -- Northern Technologies International Corporation (NASDAQ: NTIC) today announced that it expects to release its</description>
</item>
<item>
<title>Coya Therapeutics Announces Planned Board Transition and Appointment of Mark H. Pavao as Independent Director</title>
<link>https://6ix.com/company/mainz-biomed-bv/news/coya-therapeutics-announces-planned-board-transition-and-appointment-of-mark-h-pavao-as-independent-director-5</link>
<guid isPermaLink="true">https://6ix.com/company/mainz-biomed-bv/news/coya-therapeutics-announces-planned-board-transition-and-appointment-of-mark-h-pavao-as-independent-director-5</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>Howard Berman, Ph.D., the Company’s Founder and current Executive Chairman and Director, has stepped down from his roles, following the CEO transition</description>
</item>
<item>
<title>Tvardi Therapeutics to Participate in the Raymond James Biotech Innovation Symposium</title>
<link>https://6ix.com/company/mainz-biomed-bv/news/tvardi-therapeutics-to-participate-in-the-raymond-james-biotech-innovation-symposium-1</link>
<guid isPermaLink="true">https://6ix.com/company/mainz-biomed-bv/news/tvardi-therapeutics-to-participate-in-the-raymond-james-biotech-innovation-symposium-1</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>HOUSTON, April 02, 2026 (GLOBE NEWSWIRE) -- Tvardi Therapeutics, Inc. (“Tvardi”) (NASDAQ: TVRD), a clinical-stage biopharmaceutical company focused on the</description>
</item>
<item>
<title>Revolution Medicines Begins Treating Patients in Phase 3 RASolute 303 Trial Evaluating Daraxonrasib as First Line Treatment for Patients with Metastatic Pancreatic Cancer </title>
<link>https://6ix.com/company/mainz-biomed-bv/news/revolution-medicines-begins-treating-patients-in-phase-3-rasolute-303-trial-evaluating-daraxonrasib-as-first-line-treatment-for-patients-with-metastatic-pancreatic-cancer-4</link>
<guid isPermaLink="true">https://6ix.com/company/mainz-biomed-bv/news/revolution-medicines-begins-treating-patients-in-phase-3-rasolute-303-trial-evaluating-daraxonrasib-as-first-line-treatment-for-patients-with-metastatic-pancreatic-cancer-4</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>REDWOOD CITY, Calif., April 02, 2026 (GLOBE NEWSWIRE) -- Revolution Medicines, a late-stage clinical oncology company developing targeted therapies for</description>
</item>
<item>
<title>Calumet Announces First Quarter 2026 Operational Update</title>
<link>https://6ix.com/company/mainz-biomed-bv/news/calumet-announces-first-quarter-2026-operational-update</link>
<guid isPermaLink="true">https://6ix.com/company/mainz-biomed-bv/news/calumet-announces-first-quarter-2026-operational-update</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>INDIANAPOLIS, April 2, 2026 /PRNewswire/ -- Calumet, Inc. (NASDAQ: CLMT) ("Calumet" or the "Company") announced today an operational update for the first</description>
</item>
<item>
<title>Wingstop Inc. to Announce Fiscal First Quarter 2026 Financial Results on April 29, 2026</title>
<link>https://6ix.com/company/mainz-biomed-bv/news/wingstop-inc-to-announce-fiscal-first-quarter-2026-financial-results-on-april-29-2026</link>
<guid isPermaLink="true">https://6ix.com/company/mainz-biomed-bv/news/wingstop-inc-to-announce-fiscal-first-quarter-2026-financial-results-on-april-29-2026</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>DALLAS, April 2, 2026 /PRNewswire/ -- Wingstop Inc. (NASDAQ: WING) today announced that it will host a conference call and webcast to discuss its fiscal first</description>
</item>
<item>
<title>Slide to Report 2026 First Quarter Earnings Results on April 28, 2026</title>
<link>https://6ix.com/company/mainz-biomed-bv/news/slide-to-report-2026-first-quarter-earnings-results-on-april-28-2026-3</link>
<guid isPermaLink="true">https://6ix.com/company/mainz-biomed-bv/news/slide-to-report-2026-first-quarter-earnings-results-on-april-28-2026-3</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>TAMPA, Fla., April 02, 2026 (GLOBE NEWSWIRE) -- Slide Insurance Holdings, Inc. (“Slide”) (Nasdaq: SLDE) announced today it will release its 2026 first quarter</description>
</item>
<item>
<title>High Roller Technologies Regains Compliance with NYSE American Continued Listing Standards</title>
<link>https://6ix.com/company/mainz-biomed-bv/news/high-roller-technologies-regains-compliance-with-nyse-american-continued-listing-standards-3</link>
<guid isPermaLink="true">https://6ix.com/company/mainz-biomed-bv/news/high-roller-technologies-regains-compliance-with-nyse-american-continued-listing-standards-3</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>Las Vegas, Nevada, April 02, 2026 (GLOBE NEWSWIRE) -- High Roller Technologies, Inc. (“High Roller”) (NYSE: ROLR), operator of the award-winning, premium</description>
</item>
<item>
<title>Veritone and Thorn Partner to Safeguard Children Against Abuse Faster</title>
<link>https://6ix.com/company/mainz-biomed-bv/news/veritone-and-thorn-partner-to-safeguard-children-against-abuse-faster-3</link>
<guid isPermaLink="true">https://6ix.com/company/mainz-biomed-bv/news/veritone-and-thorn-partner-to-safeguard-children-against-abuse-faster-3</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>Partnership integrates Thorn’s CSAM detection AI into Veritone’s iDEMS suite, empowering law enforcement to accelerate investigations and protect vulnerable</description>
</item>
<item>
<title>Cocrystal Pharma Receives FDA Fast Track Designation for CDI-988 for Norovirus Infection Treatment and Preventive</title>
<link>https://6ix.com/company/mainz-biomed-bv/news/cocrystal-pharma-receives-fda-fast-track-designation-for-cdi-988-for-norovirus-infection-treatment-and-preventive-1</link>
<guid isPermaLink="true">https://6ix.com/company/mainz-biomed-bv/news/cocrystal-pharma-receives-fda-fast-track-designation-for-cdi-988-for-norovirus-infection-treatment-and-preventive-1</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>FDA Fast Track designation supports accelerated development and expedites regulatory reviewNorovirus is responsible for an estimated 685 million global cases</description>
</item>
<item>
<title>AC Reports Preliminary March 31 Book Value of $44.50 to $44.70 Per Share</title>
<link>https://6ix.com/company/mainz-biomed-bv/news/ac-reports-preliminary-march-31-book-value-of-dollar4450-to-dollar4470-per-share-5</link>
<guid isPermaLink="true">https://6ix.com/company/mainz-biomed-bv/news/ac-reports-preliminary-march-31-book-value-of-dollar4450-to-dollar4470-per-share-5</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>GREENWICH, Conn., April 02, 2026 (GLOBE NEWSWIRE) -- Associated Capital Group, Inc. (“AC” or the “Company”) (OTCQX: ACGP), announced today a preliminary first</description>
</item>
<item>
<title>LightInTheBox Files 2025 Annual Report on Form 20-F</title>
<link>https://6ix.com/company/mainz-biomed-bv/news/lightinthebox-files-2025-annual-report-on-form-20-f-1</link>
<guid isPermaLink="true">https://6ix.com/company/mainz-biomed-bv/news/lightinthebox-files-2025-annual-report-on-form-20-f-1</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>SINGAPORE, April 2, 2026 /PRNewswire/ -- LightInTheBox Holding Co., Ltd. (NYSE: LITB) ("LightInTheBox" or the "Company"), a global consumer lifestyle company,</description>
</item>
<item>
<title>Dorman Products, Inc. Names Kevin Olsen Chairman of The Board</title>
<link>https://6ix.com/company/mainz-biomed-bv/news/dorman-products-inc-names-kevin-olsen-chairman-of-the-board-2</link>
<guid isPermaLink="true">https://6ix.com/company/mainz-biomed-bv/news/dorman-products-inc-names-kevin-olsen-chairman-of-the-board-2</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>COLMAR, Pa., April 02, 2026 (GLOBE NEWSWIRE) -- Dorman Products, Inc. (the “Company” or “Dorman”) (NASDAQ: DORM), a leading supplier in the motor vehicle</description>
</item>
<item>
<title>Picard Medical / SynCardia COO to Deliver Keynote at Venture Café Phoenix During Arizona Tech Week</title>
<link>https://6ix.com/company/mainz-biomed-bv/news/picard-medical-syncardia-coo-to-deliver-keynote-at-venture-cafe-phoenix-during-arizona-tech-week-1</link>
<guid isPermaLink="true">https://6ix.com/company/mainz-biomed-bv/news/picard-medical-syncardia-coo-to-deliver-keynote-at-venture-cafe-phoenix-during-arizona-tech-week-1</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>– Keynote to highlight innovation in artificial heart technology and expanding access for women with advanced heart failure – TUCSON, Ariz., April 02, 2026</description>
</item>
<item>
<title>AAON Announces CFO Transition and Strengthens Executive Leadership Team</title>
<link>https://6ix.com/company/mainz-biomed-bv/news/aaon-announces-cfo-transition-and-strengthens-executive-leadership-team</link>
<guid isPermaLink="true">https://6ix.com/company/mainz-biomed-bv/news/aaon-announces-cfo-transition-and-strengthens-executive-leadership-team</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>TULSA, Okla., April 2, 2026 /PRNewswire/ -- AAON, Inc. (NASDAQ: AAON) ("AAON" or the "Company"), a leader in high-performance and energy-efficient HVAC</description>
</item>
<item>
<title>Markel Insurance appoints James Shankland as Head of Ocean Cargo, U.S.</title>
<link>https://6ix.com/company/mainz-biomed-bv/news/markel-insurance-appoints-james-shankland-as-head-of-ocean-cargo-us-1</link>
<guid isPermaLink="true">https://6ix.com/company/mainz-biomed-bv/news/markel-insurance-appoints-james-shankland-as-head-of-ocean-cargo-us-1</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>RICHMOND, Va., April 2, 2026 /PRNewswire/ -- Markel, the insurance operations within Markel Group Inc. (NYSE: MKL), announced today the appointment of James</description>
</item>
<item>
<title>Calidi Biotherapeutics to Present New Data on Its Lead Asset CLD-401 at the AACR Annual Meeting in April 2026</title>
<link>https://6ix.com/company/mainz-biomed-bv/news/calidi-biotherapeutics-to-present-new-data-on-its-lead-asset-cld-401-at-the-aacr-annual-meeting-in-april-2026-4</link>
<guid isPermaLink="true">https://6ix.com/company/mainz-biomed-bv/news/calidi-biotherapeutics-to-present-new-data-on-its-lead-asset-cld-401-at-the-aacr-annual-meeting-in-april-2026-4</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>SAN DIEGO, April 02, 2026 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi” or the “Company”), a biotechnology company</description>
</item>
</channel>
</rss>